-
Validity of Web-based, Self-directed, NeuroCognitive Performance Test in MCI
Authors:
P. Murali Doraiswamy,
Terry E. Goldberg,
Min Qian,
Alexandra R. Linares,
Adaora Nwosu,
Izael Nino,
Jessica D'Antonio,
Julia Phillips,
Charlie Ndouli,
Caroline Hellegers,
Andrew M. Michael,
Jeffrey R. Petrella,
Howards Andrews,
Joel Sneed,
Davangere P. Devanand
Abstract:
Digital cognitive tests offer several potential advantages over established paper-pencil tests but have not yet been fully evaluated for the clinical evaluation of mild cognitive impairment. The NeuroCognitive Performance Test (NCPT) is a web-based, self-directed, modular battery intended for repeated assessments of multiple cognitive domains. Our objective was to examine its relationship with the…
▽ More
Digital cognitive tests offer several potential advantages over established paper-pencil tests but have not yet been fully evaluated for the clinical evaluation of mild cognitive impairment. The NeuroCognitive Performance Test (NCPT) is a web-based, self-directed, modular battery intended for repeated assessments of multiple cognitive domains. Our objective was to examine its relationship with the ADAS-Cog and MMSE as well as with established paper-pencil tests of cognition and daily functioning in MCI. We used Spearman correlations, regressions and principal components analysis followed by a factor analysis (varimax rotated) to examine our objectives. In MCI subjects, the NCPT composite is significantly correlated with both a composite measure of established tests (r=0.78, p<0.0001) as well as with the ADAS-Cog (r=0.55, p<0.0001). Both NCPT and paper-pencil test batteries had a similar factor structure that included a large g component with a high eigenvalue. The correlation for the analogous tests (e.g. Trails A and B, learning memory tests) were significant (p<0.0001). Further, both the NCPT and established tests significantly (p< 0.01) predicted the University of California San Diego Performance-Based Skills Assessment and Functional Activities Questionnaire, measures of daily functioning. The NCPT, a web-based, self-directed, computerized test, shows high concurrent validity with established tests and hence offers promise for use as a research or clinical tool in MCI. Despite limitations such as a relatively small sample, absence of control group and cross-sectional nature, these findings are consistent with the growing literature on the promise of self-directed, web-based cognitive assessments for MCI.
△ Less
Submitted 11 July, 2022;
originally announced August 2022.
-
Digital Therapeutics for Mental Health: Is Attrition the Achilles Heel?
Authors:
Adaora Nwosu,
Samantha Boardman,
Mustafa M. Husain,
P. Murali Doraiswamy
Abstract:
Digit therapeutics are novel software devices that clinicians may utilize in delivering quality mental health care and ensuring positive outcomes. However, uptake of digital therapeutics and clinically tested software-based programs remains low. This article presents possible reasons for attrition and low engagement in clinical studies investigating digital therapeutics, analyses of studies in whi…
▽ More
Digit therapeutics are novel software devices that clinicians may utilize in delivering quality mental health care and ensuring positive outcomes. However, uptake of digital therapeutics and clinically tested software-based programs remains low. This article presents possible reasons for attrition and low engagement in clinical studies investigating digital therapeutics, analyses of studies in which engagement was high, and design constructs that may encourage user engagement. The aim is to shed light on the importance of real-world attrition data of digital therapeutics, and important characteristics of medical devices that have positively influenced user engagement. The findings presented in this article will be useful to relevant stakeholders and medical device experts tasked with addressing the gap between software medical design and user engagement present in digital therapeutic clinical trials.
△ Less
Submitted 19 July, 2022; v1 submitted 5 July, 2022;
originally announced July 2022.
-
Advancing computerized cognitive training for early Alzheimer's disease in a Covid-19 pandemic and post-pandemic world
Authors:
Kaylee A. Bodner,
Terry E. Goldberg,
D. P. Devanand,
P. Murali Doraiswamy
Abstract:
The COVID-19 pandemic has transformed mobile health applications and telemedicine from nice to have tools into essential healthcare infrastructure. This need is particularly great for the elderly who, due to their greater risk for infection, may avoid medical facilities or be required to self-isolate. These are also the very groups at highest risk for cognitive decline. For example, during the COV…
▽ More
The COVID-19 pandemic has transformed mobile health applications and telemedicine from nice to have tools into essential healthcare infrastructure. This need is particularly great for the elderly who, due to their greater risk for infection, may avoid medical facilities or be required to self-isolate. These are also the very groups at highest risk for cognitive decline. For example, during the COVID-19 pandemic artificially intelligent conversational agents were employed by hospitals and government agencies (such as the CDC) to field queries from patients about symptoms and treatments. Digital health tools also proved invaluable to provide neuropsychiatric and psychological self-help to people isolated at home or in retirement centers and nursing homes.
△ Less
Submitted 15 May, 2020; v1 submitted 29 April, 2020;
originally announced April 2020.
-
Artificial Intelligence and the Future of Psychiatry: Qualitative Findings from a Global Physician Survey
Authors:
Charlotte Blease,
Cosima Locher,
Marisa Leon-Carlyle,
P. Murali Doraiswamy
Abstract:
The potential for machine learning to disrupt the medical profession is the subject of ongoing debate within biomedical informatics. This study aimed to explore psychiatrists' opinions about the potential impact of innovations in artificial intelligence and machine learning on psychiatric practice. In Spring 2019, we conducted a web-based survey of 791 psychiatrists from 22 countries worldwide. Th…
▽ More
The potential for machine learning to disrupt the medical profession is the subject of ongoing debate within biomedical informatics. This study aimed to explore psychiatrists' opinions about the potential impact of innovations in artificial intelligence and machine learning on psychiatric practice. In Spring 2019, we conducted a web-based survey of 791 psychiatrists from 22 countries worldwide. The survey measured opinions about the likelihood future technology would fully replace physicians in performing ten key psychiatric tasks. This study involved qualitative descriptive analysis of written response to three open-ended questions in the survey. Comments were classified into four major categories in relation to the impact of future technology on patient-psychiatric interactions, the quality of patient medical care, the profession of psychiatry, and health systems. Overwhelmingly, psychiatrists were skeptical that technology could fully replace human empathy. Many predicted that 'man and machine' would increasingly collaborate in undertaking clinical decisions, with mixed opinions about the benefits and harms of such an arrangement. Participants were optimistic that technology might improve efficiencies and access to care, and reduce costs. Ethical and regulatory considerations received limited attention. This study presents timely information of psychiatrists' view about the scope of artificial intelligence and machine learning on psychiatric practice. Psychiatrists expressed divergent views about the value and impact of future technology with worrying omissions about practice guidelines, and ethical and regulatory issues.
△ Less
Submitted 22 October, 2019;
originally announced October 2019.
-
Artificial Intelligence and the Future of Psychiatry: Insights from a Global Physician Survey
Authors:
P. Murali Doraiswamy,
Charlotte Blease,
Kaylee Bodner
Abstract:
Futurists have predicted that new technologies, embedded with artificial intelligence (AI) and machine learning (ML), will lead to substantial job loss in many sectors disrupting many aspects of healthcare. Mental health appears ripe for such disruption given the global illness burden, stigma, and shortage of care providers. Using Sermo, a global networking platform open to verified and licensed p…
▽ More
Futurists have predicted that new technologies, embedded with artificial intelligence (AI) and machine learning (ML), will lead to substantial job loss in many sectors disrupting many aspects of healthcare. Mental health appears ripe for such disruption given the global illness burden, stigma, and shortage of care providers. Using Sermo, a global networking platform open to verified and licensed physicians, we measured the opinions of psychiatrists about the likelihood that future autonomous technology (referred to as AI/ML) would be able to fully replace the average psychiatrist in performing 10 key tasks (e.g. mental status exam, suicidality assessment, treatment planning) carried out in mental health care. Survey respondents were 791 psychiatrists from 22 countries. Only 3.8% of respondents felt that AI/ML was likely to replace a human clinician for providing empathetic care. Documenting (e.g. updating medical records) and synthesizing information to reach a diagnosis were the two tasks where a majority predicted that future AI/ML would replace human doctors. About 1 in 2 doctors believed their jobs could be changed substantially by future AI/ML. However, female and US-based doctors were more uncertain that the possible benefits of AI would outweigh potential risks, versus their male and global counterparts. To our knowledge, this is the first global survey to seek the opinions of physicians on the impact of autonomous AI/ML on the future of psychiatry. Our findings provide compelling insights into how physicians think about intelligent technologies which may better help us integrate such tools and reskill doctors, as needed, to enhance mental health care.
△ Less
Submitted 29 July, 2019;
originally announced July 2019.
